MAP2K7 and melanoma: A functional genomics study conducted using genome-scale open reading frame (ORF) resistance screens revealed a cyclic AMP-dependent melanocytic signaling network as another possible contributor to BRAF/MEK inhibitor resistance in melanoma [72].